Dr. Dirk Bredenbröker
Angestellt, Head of Research and Development, Unternehmensgruppe Dr. Willmar Schwabe
Karlsruhe, Deutschland
Werdegang
Berufserfahrung von Dirk Bredenbröker
Bis heute 4 Jahre und 10 Monate, seit Juli 2019
Head of Research and Development
Unternehmensgruppe Dr. Willmar Schwabe
Defining the future of phytomedicine and natural health solutions with a team of >120 highly skilled scientists and technicians, guided by our passion to innovate and help patients and customers living a better life.
2 Jahre, Juli 2017 - Juni 2019
Head of Research and Development
Bionorica SE
Transformational Leadership to build the world’s leading R&D centre of excellence in Phytomedicine & Cannabis-based medicine
4 Jahre und 2 Monate, Mai 2013 - Juni 2017
Vice President, TA Head Established Products, Global Medical Affairs
Takeda Pharmaceuticals International GmbH
Leadership of a global cross-functional team to provide R&D support and medical stewardship to a diversified portfolio of more than 500 different Established Products across >100 countries, in order to assure regulatory compliance, patients safety and medical value
9 Monate, Aug. 2012 - Apr. 2013
Head of Clinical Science Europe & Group Director Immunology/Respiratory
Takeda Pharmaceuticals International GmbH
Leadership of the Clinical Science organization for Takeda in Europe (Clinical Science, Analytical Science, Clinical Pharmacology, and Medical Writing) with staff ~70 professionals, located across four sites in Switzerland, UK, Denmark and Germany
8 Monate, Dez. 2011 - Juli 2012
Senior Director, Global Head of Medical Strategy, R&D
Nycomed: a Takeda Company
Leadership of a team of ~40 Clinical Experts and Medical Directors located at three different sites, accountable for the global clinical development strategy across the R&D portfolio in Respiratory, Rheumatology, Gastroenterology, Pain, Osteoporosis, Tissue Management, Dermatology, Diabetes
1 Jahr und 10 Monate, März 2010 - Dez. 2011
Global Head of Medical Affairs & Clinical Development Respiratory
Nycomed
Leadership of a team of > 20 professionals accountable for Clinical Development and Global Medical Affairs for the Respiratory portfolio with a focus on the global registration and launch of Daxas®,
2 Jahre, März 2008 - Feb. 2010
Executive Director European Medical Research
Mundipharma Research GmbH
Leadership of the European Medical Research organization with 60 professionals located across two sites (Germany and UK) responsible for Clinical Operations, Medical Writing, Clinical Monitoring, Medical Science, Statistics & Data Management, Clinical Pharmacology, and Medical Affairs across the R&D portfolio in Pain, Asthma, Rheumatoid Arthritis
2000 - 2008
Head of Clinical Research Pulmonology
Altana Pharma
Head of a Clinical Research department with >35 employees (International Study Managers and Medical Experts) & Global Clinical Development Leader for Daxas accountable for the worldwide clinical development (strategy & operational execution) in Asthma and COPD
1999 - 2000
International Study Manager
Byk Gulden
Responsible for preparation and conduct of global clinical trials phase 2&3 in asthma & COPD
1996 - 1999
Physician / Internal Medicine
Philipps-Universität Marburg
Three years of postgraduate training in Internal Medicine at the Division of Respiratory and Critical Care Medicine
Ausbildung von Dirk Bredenbröker
1990 - 1996
Medicine
Philipps-Universität Marburg
Sprachen
Deutsch
-
Englisch
-